Protalix BioTherapeutics, Inc. Annual Cost of Revenue in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $8.38M, a 71.2% increase year-over-year.
  • Protalix BioTherapeutics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $29.3M, a 77.3% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2023 was $23M, a 17.3% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2022 was $19.6M, a 19.8% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2021 was $16.3M, a 50.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23M +$3.39M +17.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $19.6M +$3.24M +19.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $16.3M +$5.48M +50.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $10.9M -$22K -0.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $10.9M +$1.59M +17.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $9.3M -$5.93M -38.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $15.2M +$6.83M +81.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $8.4M +$7.67M +1050% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $730K +$100K +15.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $630K +$630K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $0 -$8.14M -100% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 $8.14M +$6.62M +434% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $1.53M -$2.86M -65.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-13
2010 $4.38M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.